Status:
RECRUITING
Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement
Lead Sponsor:
Institut Pasteur
Conditions:
Deafness Neurosensory
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a cont...
Detailed Description
Longitudinal study consisting of multiple visits with multiple examinations over a total duration of approximately 3 years per ANSD participant and 1 year per normal hearing participant. * normal hea...
Eligibility Criteria
Inclusion
- For all participants:
- Age greater than or equal to 18 years,
- French mother tongue,
- Have an average tonal hearing loss (calculated according to the BIAP method) \< 30 dB HL, on headphones, for each ear,
- Be professionally active, not be pre-retired and not be unemployed
- Be affiliated with a social security plan,
- For participants with TSNA:
- \- Have degraded comprehension in noise (threshold of Intelligibility in Noise \> 3 dB compared to the norm).
- For controls:
- \- Have normal comprehension in noise (Intelligibility in Noise threshold ≤ 3 dB from the norm).
Exclusion
- For all participants:
- Have a conductive or mixed hearing loss, which is when the hearing loss affects both the outer and/or middle ear and the inner ear.
- Have an asymmetric hearing loss, i.e. a difference in average hearing loss between the left and right ear greater than 30 dB,
- Have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing (vestibular schwannoma, Meniere's disease, sudden or fluctuating deafness, congenital hypoacusis)
- Being under guardianship,
- Being deprived of liberty by judicial or administrative decision, or being subject to legal protection.
Key Trial Info
Start Date :
March 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05985473
Start Date
March 6 2024
End Date
September 15 2026
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CEntre de Recherche et d'Innovation en Audiologie Humaine
Paris, France